Eva-Lotta Allan

Eva-Lotta Allan currently serves as Non-Executive Chairman at Maxion Therapeutics and Draupnir Bio, along with holding Non-Executive Director positions at Almirall, Aleta Biotherapeutics, and Crescendo Biologics Limited. Previously, Eva-Lotta Allan was Non-Executive Chairman at C4X Discovery Ltd and Non-Executive Director at Targovax ASA. With extensive experience in the biopharmaceutical sector, roles include Chief Business Officer at Immunocore and Ablynx, and Senior Director of Global Business Development and European Operations at Vertex. Expertise encompasses strategic leadership and business development within the biotechnology industry.